Key result
Implantation of a new sutureless aortic valve (Perceval Sorin) was feasible in 16 high-risk patients, resulting in no paravalvular leakage and a median cross-clamping time of 36 minutes.
Why the study?
Does a sutureless aortic valve implanted via an open approach demonstrate feasibility and safety in high-risk patients with significant aortic valve disease?
Does a sutureless aortic valve implanted via an open approach demonstrate feasibility and safety in high-risk patients with significant aortic valve disease?
Initial human implants of a new sutureless aortic valve via an open approach demonstrated feasibility, short cross-clamp times, and excellent immediate hemodynamic performance without paravalvular leak.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in high-risk aortic valve replacement; leaves open the role of sutureless valves pending prospective trials.
OBJECTIVE: Percutaneous implantable aortic valves may become an alternative to conventional approaches. The purpose of this study was to assess a new sutureless aortic valve (Perceval Sorin). As a first step, an open approach using cardiopulmonary bypass (CPB) was chosen to evaluate the feasibility of implantation. METHODS: Between April and September 2007, 16 high-risk patients (13 females, aged 81 [76 - 88]) were operated on via a median sternotomy, using CPB and cardioplegia (Euro Score 17 [8 - 73]). All patients had significant aortic valve disease and seven of these patients had concomitant coronary artery disease. This pilot project was initiated with prior approval of the Institutional Review Board. All patients gave informed consent. RESULTS: One patient died during hospital stay for unknown reasons. Autopsy revealed no valve related pathologies. CPB time was 60 min (41 - 130), cross-clamping time was 36 (22 - 79) min. Intraoperative as well as postoperative echocardiography revealed neither aortic insufficiency nor paravalvular leakage in any of the patients. CONCLUSIONS: The new approach as described here is a technically simple alternative to conventional aortic valve replacement in high-risk patients and offers the potential of less invasive approaches. It appears especially useful in patients with severe calcification of the aortic root. CPB and cross-clamping times were markedly reduced compared with patients who underwent conventional operations.
No takes yet. Share an insight, caveat, or question.
Shrestha et al. (2008) studied significant aortic valve disease (n=16). Sutureless aortic valve (Perceval Sorin) was evaluated on feasibility of implantation. Implantation of a new sutureless aortic valve (Perceval Sorin) was feasible in 16 high-risk patients, resulting in no paravalvular leakage and a median cross-clamping time of 36 minutes.
Synapse has enriched 10 related papers. Consider them for comparative context: